Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
This is from a few months ago. These funds have been mentioned a few times on the board lately in the healthcare threads and thought this might be of interest. It covers the two main funds, but also goes considerably in-depth into the world of biotech, with guest speakers from portfolio companies and a panel discussion, no less.
Thanks @scott!! I'm not sure when I'll have time to watch all of this but I'm one of those HQL guys and I'm sure this will be worth watching.
It is (at least I thought.) I've always been one of those people who have said, "I don't understand medical terminology, I'll leave that up to the funds." However, I decided to start researching to learn more both from an investment standpoint and from my own intellectual curiosity. The presentation both made me more confident in the HQL/HQH funds, but also has me interested in branching out and looking at additional individual healthcare/biotech companies.
Comments